Literature DB >> 34410568

Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.

Molly E Ream1, Emily A Walsh2, Jamie M Jacobs3,4, Chloe Taub2, Marc Lippman5, Natasha Schaefer-Solle6, Steven A Safren2, Michael H Antoni2,7.   

Abstract

PURPOSE: Despite life-saving potential, many women struggle to adhere to adjuvant endocrine therapy (AET) for their breast cancer (BCa). Prior research has demonstrated that emotional distress is a barrier to AET adherence. We followed women from a trial to test the long-term effects of two 5-week post-surgical group-based stress management interventions, cognitive behavioral therapy (CBT), and relaxation training versus an attention-matched health education control, on AET adherence.
METHODS: We conducted a long-term follow-up (median = 8 years) of women randomized to CBT, relaxation training, or health education after surgery for stage 0-3 BCa. We measured adherence with the Endocrine Therapy Medication Usage Questionnaire (ETMUQ). First, we established factors on the ETMUQ via confirmatory factor analysis. We then used Bayesian structural equation modeling to regress these factors on study arm, controlling for age and treatments received.
RESULTS: Of those who completed long-term follow-up (n = 59, 44.7%), over half (n = 33; 55.9%) reported problems with adherence generally. Women receiving relaxation training (n = 15) had better adherence than those receiving health education (n = 24) on the Forgetfulness/Inconsistency [B(SE) = 0.25(0.14), p = 0.049] and Intentional Nonadherence [B(SE) = 0.31(0.14), p = 0.018] factors of the ETMUQ. Similar results were observed for those receiving relaxation training compared to CBT (n = 20): Forgetfulness/Inconsistency [B(SE) = - 0.47(0.25), p = 0.031]; Intentional Nonadherence [B(SE) = - 0.31(0.15), p = 0.027].
CONCLUSION: Women receiving relaxation training were less likely to (1) forget to take their AET and (2) intentionally miss doses of AET in the long term compared to women receiving health education or CBT. This is evidence for the need of randomized trials that aim to improve adherence by incorporating theoretically based behavioral change techniques. TRIAL REGISTRATION AND DATES: Trial 2R01-CA-064710 was registered March 26, 2006.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adherence; Behavior change; Breast cancer; Endocrine therapy; Psycho-oncology

Mesh:

Year:  2021        PMID: 34410568      PMCID: PMC9245682          DOI: 10.1007/s10549-021-06361-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  48 in total

1.  Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.

Authors:  Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg
Journal:  Am J Public Health       Date:  2012-06-21       Impact factor: 9.308

2.  Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection.

Authors:  Anna Kovalchuk; Bryan Kolb
Journal:  Cell Cycle       Date:  2017-06-28       Impact factor: 4.534

Review 3.  The mindful brain and emotion regulation in mood disorders.

Authors:  Norman A S Farb; Adam K Anderson; Zindel V Segal
Journal:  Can J Psychiatry       Date:  2012-02       Impact factor: 4.356

4.  Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.

Authors:  Annette L Stanton; Keith J Petrie; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2014-04-30       Impact factor: 4.872

5.  Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.

Authors:  P Gupta; D W Sturdee; S L Palin; K Majumder; R Fear; T Marshall; I Paterson
Journal:  Climacteric       Date:  2006-02       Impact factor: 3.005

6.  Depression and anxiety in women with early breast cancer: five year observational cohort study.

Authors:  Caroline Burgess; Victoria Cornelius; Sharon Love; Jill Graham; Michael Richards; Amanda Ramirez
Journal:  BMJ       Date:  2005-02-04

7.  Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.

Authors:  Yihang Liu; Jennifer L Malin; Allison L Diamant; Amardeep Thind; Rose C Maly
Journal:  Breast Cancer Res Treat       Date:  2012-12-23       Impact factor: 4.872

8.  Correspondence Between Objective and Self-reported Endocrine Therapy Adherence Among Women With Breast Cancer.

Authors:  Emma E Bright; Annette L Stanton
Journal:  Ann Behav Med       Date:  2019-08-16

9.  Effects of brief stress management interventions on distress and leukocyte nuclear factor kappa B expression during primary treatment for breast cancer: A randomized trial.

Authors:  Alain Diaz; Chloe J Taub; Marc E Lippman; Michael H Antoni; Bonnie B Blomberg
Journal:  Psychoneuroendocrinology       Date:  2021-02-04       Impact factor: 4.693

10.  Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.

Authors:  Jamie M Jacobs; Emily A Walsh; Chelsea S Rapoport; Michael H Antoni; Elyse R Park; Kathryn Post; Amy Comander; Jeffrey Peppercorn; Steven A Safren; Jennifer S Temel; Joseph A Greer
Journal:  J Clin Psychol Med Settings       Date:  2020-11-21
View more
  1 in total

Review 1.  Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.

Authors:  Agnieszka D Sekula; Luke Downey; Prashanth Puspanathan
Journal:  Front Psychol       Date:  2022-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.